tiprankstipranks

Douglas Carr Insider Profile

4 Followers
Douglas Carr, SVP Finance & Operations at Century Therapeutics, holds 317.58K shares in Century Therapeutics (Ticker: IPSC).
tipranks
Douglas Carr

Douglas Carr
Century Therapeutics (IPSC)
SVP Finance & Operations

Not Ranked
Douglas Carr has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$915K
100.00%
A breakdown of Douglas Carr's holdings

Insider Roles

Century Therapeutics
(IPSC)
SVP Finance & Operations
Roles that Douglas Carr holds in companies

Most Profitable Insider Trade

Stock:
Century Therapeutics
(IPSC)
Rating:Informative Sell
Date:Feb 07, 2024 - Today
Return:+32.20%
The most profitable trade made by Douglas Carr

Douglas Carr's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Century Therapeutics
Mar 11, 2024
SVP Finance & Operations
Uninformative Buy
$914.63K
Success Rate for
IPSC
1 out of 1 profitable transactions on
IPSC
100%
Average Return for
IPSC
Average return per transaction on
IPSC
+32.20%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 17, 2023
Uninformative Buy
$0.00
-
$0.00
Mar 11, 2024
Uninformative Buy
$0.00
-
$0.00
Nov 03, 2023
Uninformative Sell
$24.75K
-
$1.49
Feb 07, 2024
Informative Sell
$4.96K
-
$4.13
+32.20%
Feb 06, 2023
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Douglas Carr's performance on stock

Douglas Carr insider profile FAQ

What is the percentage of profitable transactions made by Douglas Carr?
The percentage of profitable transactions made by Douglas Carr is ―.
    What is the average return per transaction made by Douglas Carr?
    The average return per transaction made by Douglas Carr is ―.
      What stocks does Douglas Carr hold?
      Douglas Carr holds: IPSC stocks.
        What was Douglas Carr’s latest transaction?
        Douglas Carr latest transaction was an Uninformative Buy of ―.
          What was Douglas Carr's most profitable transaction?
          Douglas Carr’s most profitable transaction was an Informative Sell of IPSC stock on February 7, 2024. The return on the trade was 32.20%.
            What is Douglas Carr's role in Century Therapeutics?
            Douglas Carr's role in Century Therapeutics is SVP Finance & Operations.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.